Doug Hampton

Inhibikase Therapeutics Announces Dosing of First Patient in its Phase 2 ‘201’ Clinical Trial of IkT-148009 to Treat Parkinson’s Disease

by

BOSTON and ATLANTA, May 16, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson’s disease and related disorders, today announced that the first patient has been dosed in its Phase 2 ‘201’ trial evaluating IkT-148009, the Company’s novel Abelson Tyrosine Kinase, or c-Abl, … Read more

Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

by

Phase 3 PL9643 Data in Patients with Dry Eye Disease Presented at KOL Event Analysis of Lead-In Population of Initial 120 Patients Showed Statistical Separation for Clinical Efficacy Across Multiple Signs and Symptoms of Dry Eye along with Excellent Patient Safety and Tolerability Final Data Expected Second Half Calendar Year 2023 Phase 2 Clinical Study … Read more

BOTTICELLI, L’INQUIÉTUDE ET LA BEAUTÉ

by

FLORENCE, Italie, 16 mai 2023 /PRNewswire/ — Artiste à succès, interprète sensible de la culture de son temps et auteur d’œuvres d’une extraordinaire pertinence, Sandro Botticelli était un maître de la beauté. Avec ses « Vénus », il a établi, sans le savoir, un canon de perfection qui reflète étroitement celui de l’époque moderne. Pourtant, il était un … Read more

BOTTICELLI, LA INQUIETUD Y LA BELLEZA — Menarini presenta en Florencia su última monografía de arte, dedicada al símbolo del renacimiento italiano

by

FLORENCIA, Italia, 16 de mayo de 2023 /PRNewswire/ — Artista de éxito, intérprete sensible de la cultura de su tiempo y autor de obras de extraordinaria relevancia, Sandro Botticelli fue un maestro de la belleza. Con sus “Venus”, estableció, sin saberlo, un canon de perfección que refleja fielmente el de la actualidad.  Sin embargo, era una figura … Read more

Sunshine Health and Johns Hopkins All Children’s Care Network Enter Value-Based Care Agreement to Better Serve Medicaid Recipients

by

Partnership provides in-network access with more than 160 primary care providers serving 56,000 Sunshine Health members TAMPA, Fla., May 16, 2023 /PRNewswire/ — Sunshine Health, a leading Medicaid managed care organization in Florida, and Johns Hopkins All Children’s Hospital, a premiere clinical and academic health system providing expert pediatric care for infants, children and teens … Read more

NRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

by

Enrollment continues in the Phase 2b/3 clinical trial evaluating NRX-101 in Suicidal Treatment-Resistant Bipolar Depression; data expected in 4Q 2023 National educational campaign launched to further accelerate enrollment in Breakthrough Therapy Designation meeting for NRX-101 in Suicidal Treatment-Resistant Bipolar Depression with the U.S. FDA planned for 2Q 2023; on track to report topline clinical data … Read more

Eating broccoli may limit skin allergies, study finds

by

(AFP) – Eating broccoli or cabbage would limit the severity of skin allergies, indicates a study presented Tuesday by Inserm, which underlines the importance of a balanced diet for patients suffering from these skin reactions. In this study published in the English-language scientific journal eLife, researchers from the National Institute for Health and Medical Research … Read more

The Caris Precision Oncology Alliance Welcomes Robert H. Lurie Comprehensive Cancer Center of Northwestern University

by

Lurie Cancer Center joins Caris’ extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine IRVING, Texas, May 16, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that Robert H. Lurie Comprehensive Cancer … Read more

Nuclear Medicine Market to be Worth $22.3 Billion by 2030: Grand View Research, Inc.

by

SAN FRANCISCO, May 16, 2023 /PRNewswire/ – The global nuclear medicine market size is expected to reach USD 22.3 billion by 2030, registering a CAGR of 11.8% over the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer & thyroid is anticipated to drive … Read more